drugset / Trial / NCT03664752

Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

NCT03664752 ↗

Phase 3 Completed 585 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

study designed to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel

Timeline

Start
2018-12-10
Primary completion
2020-05-07
Completion
2020-05-07

Drugs

EvaluationDrugModalityDoseRoute
Subject IDP-120 Gel Unknown — —

Indications